Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon R Pine

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Leukemia Research|January 16, 2003
TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemiaSharon R Pine, Joseph L Wiemels, S Jayabose, et al.
Frontiers in Oncology|February 28, 2018
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized TherapyMichele Patrizii, Monica Bartucci, Sharon R Pine, et al.
Carcinogenesis|October 27, 2025
Eighty years of cancer research after the atomic bombings of Hiroshima and NagasakiJonathan M Samet, Preetha Rajaraman, Sharon R Pine, et al.
Carcinogenesis|August 20, 2021
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistanceHatem E Sabaawy, Bríd M Ryan, Hossein Khiabanian, et al.
Theranostics|November 23, 2019
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapyOlga B Garbuzenko, Andriy Kuzmov, Oleh Taratula, et al.
Carcinogenesis|November 22, 2024
Editorial: special issue on the latest advances and challenges in pancreas cancer research in memory of S. Perwez HussainChristine Alewine, Curtis C Harris, Anirban Maitra, et al.
Frontiers in Oncology|February 4, 2017
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized MedicineKatherine M Morgan, Gregory M Riedlinger, Jeffrey Rosenfeld, et al.
Frontiers in Oncology|July 23, 2025
Editorial: Advancements in drug development: exploring bi-specific antibodies as promising therapeutic strategies in oncologyUrs M Weber, Julie M Bailis, Angela Coxon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Microenvironmental modulation of asymmetric cell division in human lung cancer cellsSharon R Pine, Bríd M Ryan, Lyuba Varticovski, et al.
Blood|June 20, 2007
Incidence and clinical implications of GATA1 mutations in newborns with Down syndromeSharon R Pine, Qianxu Guo, Changhong Yin, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Leukemia Research|January 16, 2003
TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemiaSharon R Pine, Joseph L Wiemels, S Jayabose, et al.
Frontiers in Oncology|February 28, 2018
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized TherapyMichele Patrizii, Monica Bartucci, Sharon R Pine, et al.
Carcinogenesis|October 27, 2025
Eighty years of cancer research after the atomic bombings of Hiroshima and NagasakiJonathan M Samet, Preetha Rajaraman, Sharon R Pine, et al.
Carcinogenesis|August 20, 2021
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistanceHatem E Sabaawy, Bríd M Ryan, Hossein Khiabanian, et al.
Theranostics|November 23, 2019
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapyOlga B Garbuzenko, Andriy Kuzmov, Oleh Taratula, et al.
Carcinogenesis|November 22, 2024
Editorial: special issue on the latest advances and challenges in pancreas cancer research in memory of S. Perwez HussainChristine Alewine, Curtis C Harris, Anirban Maitra, et al.
Frontiers in Oncology|February 4, 2017
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized MedicineKatherine M Morgan, Gregory M Riedlinger, Jeffrey Rosenfeld, et al.
Frontiers in Oncology|July 23, 2025
Editorial: Advancements in drug development: exploring bi-specific antibodies as promising therapeutic strategies in oncologyUrs M Weber, Julie M Bailis, Angela Coxon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Microenvironmental modulation of asymmetric cell division in human lung cancer cellsSharon R Pine, Bríd M Ryan, Lyuba Varticovski, et al.
Blood|June 20, 2007
Incidence and clinical implications of GATA1 mutations in newborns with Down syndromeSharon R Pine, Qianxu Guo, Changhong Yin, et al.
Pageof 7